Scailyte Company
Scailyte has established a data-driven biomarker discovery platform that leverages unique expertise in single-cell data analysis and artificial intelligence. We are utilizing this platform to discover a new class of biomarkers, which are defined by the molecular profiles of disease-associated cells. This phenotypic approach to biomarker discovery is radically new and directly related to the biology of a disease, which maximizes the success rate for discovering sensitive and robust biomarkers.
.jpg)
Technology:
Intelligent Data Analysis
Industry:
Clinical Data Management
Headquarters:
Basel
Employees Number:
11-50
Estimated Revenue:
Less than $1M
Register and Claim Ownership